Universal Genetic Testing Is Far From a Reality in Patients With Ovarian Cancer
A new review points to low rates of genetic testing in patients with ovarian cancer.
Gynecologic, Ovarian, and Cervical Cancer
GYNECOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Oral Contraceptives Found to Protect Against Ovarian and Endometrial Cancer for up to 35 Years After Discontinuation
Investigators of the observational study sought to clarify the time-dependent effects between long-term oral contraceptive use and risk for breast, ovarian, and endometrial cancer risk. -
American Cancer Society Updates Cervical Cancer Screening Guidelines
New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing. -
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline
The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings. -
Clinical Utility of Deep Phenotyping and Whole-Genome Risk Assessment in Early Cancer Detection and Precision Oncology
State-of-the-art advanced imaging coupled with whole-genome sequencing shows utility in early cancer detection and cancer-associated pathogenic variant detection.
GYNECOLOGIC CANCER NEWS
Survival Rates Not Improving for AYAs With Sarcomas or Breast, Gynecologic Cancers
TVUS ET Screening Misses More Cases of Endometrial Cancer in Black Women Than in White Women
Novel Genetic Variants Are Associated With Increased Risk of Cervical Cancer
Keytruda Plus Lenvima Gets Full Approval for Advanced Endometrial Cancer
Removing a Large Uterus via Minimally Invasive Surgery Linked to Local Recurrence of High-Grade Endometrial Cancer
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Gynecologic Cancer
Loading... 
Loading...